The Evidence-based Medicine Paradigm: Where are We 20 Years Later? Part 1

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  2013-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S0317167100014542PMID 23786728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence-based.

  2019cited by this paper
• Bladder Management With Epidural Anesthesia During Labor: A Randomized Controlled Trial

  2015cited by this paper
• Wikipedia

  2014cited by this paper
• Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it?

  2013cited by this paper
• Stopping trials early.

  2013cited by this paper
• Validity and Inter-rater Reliability Testing of Quality Assessment Instruments

  2013cited by this paper
• The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

  2012cited by this paper
• Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments

  2012cited by this paper
• StaR Child Health: Developing Evidence-Based Guidance for the Design, Conduct, and Reporting of Pediatric Trials

  2012cited by this paper
• Enrollment of Extremely Low Birth Weight Infants in a Clinical Research Study May Not Be Representative

  2012cited by this paper
• Evidence-based medicine: promise and pitfalls

  2012cited by this paper
• Biases in the Evaluation of Psychiatric Clinical Evidence

  2012cited by this paper
• Credibility of claims of subgroup effects in randomised controlled trials: systematic review

  2012cited by this paper
• The effect of clinical history on accuracy of electrocardiograph interpretation among doctors working in emergency departments

  2012cited by this paper
• Problems of stopping trials early

  2012cited by this paper
• Evidence-based medicine: revisiting the pyramid of priorities.

  2012cited by this paper
• Enrollment of Extremely Low Birth Weight Infants in a Clinical Research Study May Not Be Representative

  2012cited by this paper
• Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data

  2012cited by this paper
• Surrogate end points: studying their benefits, taxonomy, and semantics

  2012cited by this paper
• Criminals in the Citadel and Deceit all along the Watchtower: Irresponsibility, Fraud, and Complicity in the Search for Scientific Truth

  2012cited by this paper
• Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study

  2012cited by this paper
• Perspectives on diagnostic failure and patient safety.

  2012cited by this paper
• The end of evidence-based medicine?

  2012cited by this paper
• What influences clinical decision making?

  2012cited by this paper
• Conflict of Interest Policies for Organizations Producing a Large Number of Clinical Practice Guidelines

  2012cited by this paper
• Standard 4: Determining Adequate Sample Sizes

  2012cited by this paper
• Pitfalls

  2012cited by this paper
• Neurology: An evidence-based approach

  2012cited by this paper
• The Hierarchy of Evidence: From Unsystematic Clinical Observations to Systematic Reviews

  2012cited by this paper
• The EPIQ evidence reviews - practical tools for an integrated approach to knowledge translation.

  2011cited by this paper
• Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines

  2011cited by this paper
• Sex Bias in Studies Selected for Clinical Guidelines

  2011cited by this paper
• How applicable are clinical practice guidelines to elderly patients with comorbidities?

  2011cited by this paper
• StaR Child Health: Developing Evidence‐Based Guidance for the Design, Conduct, and Reporting of Pediatric Trials

  2011cited by this paper
• Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.

  2011cited by this paper
• Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey

  2011cited by this paper
• Is meta-analysis the platinum standard of evidence?

  2011cited by this paper
• Breaking Free of Sample Size Dogma to Perform Innovative Translational Research

  2011cited by this paper
• Reporting of clinical trials: publication, authorship, and trial registration.

  2011cited by this paper
• Clinical practice guidelines: the need for greater transparency in formulating recommendations

  2011cited by this paper
• Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study

  2011cited by this paper
• What have we learnt from the rosiglitazone saga?

  2011cited by this paper
• GRADE guidelines 6. Rating the quality of evidence--imprecision.

  2011cited by this paper
• Evidence-based medicine: can the evidence be trusted?

  2011cited by this paper
• Reviews

  2011cited by this paper
• Evidence-based practice: triumph of style over substance?

  2011cited by this paper
• The idolatry of the surrogate

  2011cited by this paper
• Hippocampal stimulation in the treatment of epilepsy.

  2011cited by this paper
• Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature.

  2011cited by this paper
• New anti-epileptic drugs: overcoming the limits of randomised controlled trials.

  2011cited by this paper
• A pragmatic view on pragmatic trials

  2011cited by this paper
• The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution

  2010cited by this paper
• Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review

  2010cited by this paper
• CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials

  2010cited by this paper
• Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review

  2010cited by this paper
• Modified intention to treat reporting in randomised controlled trials: systematic review

  2010cited by this paper
• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials

  2010cited by this paper
• Evidence: To see or not to see.

  2010cited by this paper
• A descriptive analysis of child-relevant systematic reviews in the Cochrane Database of Systematic Reviews

  2010cited by this paper
• Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study

  2010cited by this paper
• Sample Size Estimation in Clinical Trial

  2010cited by this paper
• The U.S. Healthcare System

  2010cited by this paper
• How to Read a Paper

  2010cited by this paper
• Current sample size conventions: Flaws, harms, and alternatives

  2010cited by this paper
• Ain't necessarily so: review and critique of recent meta-analyses of behavioral medicine interventions in health psychology.

  2010cited by this paper
• Rosiglitazone, marketing, and medical science

  2010cited by this paper
• Clinical Practice Guidelines - The Warped Incentives in the U.S. Healthcare System

  2010cited by this paper
• StaR Child Health: an initiative for RCTs in children.

  2009cited by this paper
• Reporting of sample size calculation in randomised controlled trials: review

  2009cited by this paper
• A universal model of diagnostic reasoning.

  2009cited by this paper
• A systematic review of Cochrane anticoagulation reviews.

  2009cited by this paper
• Context is everything or how could I have been that stupid?

  2009cited by this paper
• Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials.

  2009cited by this paper
• Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.

  2009cited by this paper
• The Nature of Evidence in Evidence-Based Medicine: Guest Editors’ Introduction

  2009cited by this paper
• The Randomized Controlled Trial

  2009cited by this paper
• Lost in a jungle of evidence: We need a compass

  2009cited by this paper
• Epistemologic inquiries in evidence-based medicine.

  2009cited by this paper
• Practice parameters and technology assessments: What they are, what they are not, and why you should care

  2009cited by this paper
• Diagnostic strategies used in primary care

  2009cited by this paper
• Measurement in clinical trials: A neglected issue for statisticians?

  2009cited by this paper
• Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials

  2009cited by this paper
• How doctors feel: affective issues in patients' safety.

  2008cited by this paper
• Moving Toward Transparency of Clinical Trials

  2008cited by this paper
• Invited Article: Lost in a jungle of evidence

  2008cited by this paper
• Generalizability of the results of randomized trials.

  2008cited by this paper
• A dirty dozen: twelve p-value misconceptions.

  2008cited by this paper
• Was the study big enough? Two café rules.

  2008cited by this paper
• The “number needed to treat” turns 20 — and continues to be used and misused

  2008cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• Progress in evidence-based medicine.

  2008cited by this paper
• De testimonio: on the evidence for decisions about the use of therapeutic interventions.

  2008cited by this paper
• Children Are Not Just Small Adults: The Urgent Need for High-Quality Trial Evidence in Children

  2008cited by this paper
• Faculty Opinions recommendation of Medicine. Moving toward transparency of clinical trials.

  2008cited by this paper
• Invited Article: Practice parameters and technology assessments

  2008cited by this paper
• Statistics in Brief: The Importance of Sample Size in the Planning and Interpretation of Medical Research

  2008cited by this paper
• The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?

  2007cited by this paper
• Recommendations

  2007cited by this paper
• Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials

  2007cited by this paper
• Statistics in medicine--reporting of subgroup analyses in clinical trials.

  2007cited by this paper

• Navigating under pressure: psychotherapists' experiences in a randomized controlled trial of posttraumatic stress disorder related to childhood maltreatment.

  2025cites this paper
• Web-Based Educational Intervention to Improve Knowledge of Systematic Reviews Among Health Science Professionals: Randomized Controlled Trial

  2022cites this paper
• The effectiveness of short-term psychodynamic psychotherapy in depression and anxiety disorders

  2021cites this paper
• Artificial Intelligence and Patient-Centered Decision-Making

  2020cites this paper
• The role of tacit knowledge in communication and decision-making during emerging public health incidents

  2020cites this paper
• The TRIVIA Cohort for Surgical Management of Tetralogy of Fallot: Merging Population and Clinical Data for Real-World Scientific Evidence

  2020cites this paper
• Psychoanalysis and evaluation: a stratified model focused on the uniqueness of the case

  2019cites this paper
• The efficacy of psychodynamic psychotherapy: an up-to-date review

  2019cites this paper
• The case for stepped care: Exploring the applicability and cost-utility of stepped-care strategies in the management of depression

  2018cites this paper
• The Empirical Status of Psychodynamic Psychotherapy - An Update: Bambi's Alive and Kicking

  2015cites this paper
• Psychodynamic therapy meets evidence-based medicine: a systematic review using updated criteria.

  2015cites this paper
• A 'reluctant' critical review: 'Manual for evidence-based clinical practice (2015)'.

  2015cites this paper
• Evidenzbasierte Medizin: Vorbild für die Suchtprävention?

  2015cites this paper
• Evidence based on what?

  2015cites this paper
• REVISITING THE EVIDENCE - BASED MEDICINE PARADIGM - THE NEED TO BE AWARE OF ITS LIMITATIONS. A QUICK OVERVIEW AND A BRIEF REVIEW OF SOME RECENT CRITIQUES

  2015cites this paper
• Draft Guideline for the Development of Evidence Based Medicine-Related Apps

  2015cites this paper
• Tendencies in medical publications

  2015cites this paper
• Awareness, knowledge, use, and attitudes toward evidence based medicine in a developing country: survey of physicians in a canton in Bosnia and Herzegovina

  2015cites this paper
• From the editor

  2014cites this paper
• Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneic hematopoietic stem cell transplantation: a systematic review

  2014cites this paper
• Evidence-informed person-centered healthcare part I: do 'cognitive biases plus' at organizational levels influence quality of evidence?

  2014cites this paper
• Response to the Letter to the Editor

  2014cites this paper
• Integrative oncology: really the best of both worlds?

  2014cites this paper
• Evidence-informed person-centred health care (part II): are 'cognitive biases plus' underlying the EBM paradigm responsible for undermining the quality of evidence?

  2014cites this paper
• Consistent Components of Behavior Change Theories

  2014cites this paper
• Evidence-based medicine should be based on science.

  2013cites this paper
• Evidence-Based Medicine 20 Years On: A View from the Inside

  2013cites this paper
• Muckart responds.

  2013cites this paper